Romaciclib
SEL120-34A is a potent, selective, orally available, ATP-competitive CDK8 inhibitor, with IC50s of 4.4 nM and 10.4 nM for CDK8/CycC and CDK19/CycC, respectively, with antitumor activity.
Product Specifications
CAS Number
[1609522-33-9]
Product Name Alternative
SEL120-34A
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/CDK8-IN-2.html
Purity
99.49
Solubility
10 mM in DMSO
Smiles
CC1=C2C3=C(C(Br)=C1Br)CCCN3C(N4CCNCC4)=N2
Molecular Formula
C15H18Br2N4
Molecular Weight
414.14
References & Citations
[1]Rzymski T, et al. SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains. Oncotarget. 2017 May 16;8 (20) :33779-33795.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK19; CDK8; CDK9
Citation 01
Friedrich-Alexander-Universität Erlangen-Nürnberg. 2023 Jun 23.|Nat Commun. 2024 Mar 19;15 (1) :2198.|Nat Commun. 2019 Oct 18;10 (1) :4741. |Adv Sci (Weinh) . 2025 Nov 19:e18346.|bioRxiv. 2025 January 24.|Cell. 2021 Apr 15;184 (8) :2167-2182.e22.|Int J Mol Sci. 2022 Feb 24;23 (5) :2493.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
D1065-50I-ML490 100 µL
DARC (NT) (Duffy Antigen/Chemokine Receptor, Duffy Antigen/Chemokine Receptor, Fy Glycoprotein D, GpFy, Cell Adhesion Molecule 3, CADM3, Plasmodium Vivax Receptor, CCBP1, CD234, CD234 antigen, Dfy, GpFy, Plasmodium vivax receptor) (MaxLight 490)
Ask
View Details 171197 50 µg
RAI3 (GPRC5A, RAIG-1, Retinoic Acid induced 3, Retinoic Acid Responsive, GPCR5A, RAI3, RAIG1, Retinoic Acid-inducible gene 1)
Ask
View Details